#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy proliferative Hypophosphatasia MELAS syndrome Blood iron increased Small for dates baby Sjogren's syndrome Polymyositis Ventricular tachycardia Postprandial hypoglycaemia Colon cancer Amyloidosis Cutaneous T-cell lymphoma recurrent Chondrosarcoma White matter lesion Juvenile idiopathic arthritis More trials…

    Learn about Rare Diseases

    Inclusion body myositis – Diagnostics Ewing’s sarcoma – Trials in Disease Soft tissue sarcoma – Trials in Disease Arterial tortuosity syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent Atypical haemolytic uraemic syndrome – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Lymphangiosarcoma Prolymphocytic leukaemia – Treatment Mucopolysaccharidosis III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Farletuzumab Ecteribulin Tinengotinib Glipizide Festuca Rubra Pollen Calcium Pantothenate Bp Ethinylestradiol Coffee Charcoal HYDROMORPHONE HYDROCHLORIDE Resiniferatoxin RUBIDIUM CHLORIDE Cabotegravir Mps-213 Lisocabtagene Maraleucel Icosapent Ethyl Rizolipase Rineterkib Sodium Picosulfate Clindamycin Phosphate SAR443820 Naxitamab More therapies…

    Learn about Your Condition

    Corticobasal degeneration Asplenia Acne Peritoneal abscess Ulcerative keratitis Eructation Respiratory distress Paraesthesia Alcoholic liver disease Spondylolisthesis Becker's muscular dystrophy Thermal burn K-ras gene mutation Congenital myopathy Cardiac ventricular thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Sahlgrenska University Hospital-Vastra Gotalandsregionen…

Sahlgrenska University Hospital-Vastra Gotalandsregionen

Goteborgsvagen 31, Fassberg, Molndal, 431 30, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5

  • Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5

  • Study Comparing Bevacizumab and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Bevacizumab
    Sweden

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!